Hirudin elimination by hemofiltration. a comparative in vitro study of different membranes

Kidney International, Supplement

Volumn 56, Issue 72, 1999, Pages

  Frank, Rolf D ^a,b   Farber, Heiko ^a   Stefanidis, Ioannis ^a   Lanzmicii, Regina ^a   Kierdorf, Horst P ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Dialysis membrane; Hemofilter; Membrane biocompatibility; Sieving coefficient

Indexed keywords

HEPARIN; HIRUDIN DERIVATIVE; PROTHROMBIN; RECOMBINANT PROTEIN; LEPIRUDIN;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD; COMPARATIVE STUDY; DRUG DETOXIFICATION; HEMOFILTRATION; HUMAN; METHODOLOGY; MIDDLE AGED; DIALYSIS MEMBRANE; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; HEMOFILTRATION; HEPARIN; HIRUDINS; HUMANS; MEMBRANES, ARTIFICIAL; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; PROTHROMBIN; RECOMBINANT PROTEINS;

EID: 0032703077     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. ERIKSSON BI, EKMAN S, KäLEBO P, ZACHRISSON B, BACH D, CLOSE P. Prevention of deep-vein thrombosis after total hip replacement. Direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 347:635-639, 1996
2. SCHIELE F, LINDGAERDE F, ERIKSSON H, BASSAND JP, WALLMARK A, HANSSON PO, GROLLIER G, Sjo M, MOIA M, CAMEZ A, SMYTH V, WALKER M. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs. A multicentre prospective dose-ranging trial. Thromb Haemost 77:834-838, 1997
3. THE OASIS INVESTIGATORS. Comparison of the effect of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation. A pilot study. Circulation 96:769-777, 1997
4. THE GUSTO HB INVESTIGATORS. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N EnglJ Med 335:775-782, 1996
5. DICKNEITE G, CZECH J. Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis. Thromb Haemost 71:768-772,1994
6. VANHOLDER RC, CAMEZ A, VEYS NM, SORIA J, MIRSHAHI M, SORIA C, RINGOIR S. Recombinant hirudin. A specific thrombin inhibiting anticoagulant for hemodialysis. Kidney frit 45:1754-1759, 1994
7. VAN WYK V, BADENHORST PN, KOTZE HF. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis. Clin Nephrol 48:381-387, 1997
8. MARKWARDT F. The development of hirudin as an antithrombotic drug. Thromb Res 74:1-23, 1994
9. NOWAK G. Pharmacokinetics of hirudin. Semin Thromb Hemostas 17:145-149, 1991
10. NOWAK G, BUCHA E, GööCK T, THIELER H, MARKWARDT F. Pharmacology of r-hirudin in renal impairment. Thromb Res 66:707-715, 1992
11. VANHOLDER R, CAMEZ A, VEYS N, VAN Loo A, DHONDT AM, RINGOIR S. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients. Thromb Haemostas 77:650655, 1997
12. BAUERSACHS EM, LINDHOFF-LAST E, EHRLY AM, BETZ C, GEIGER H, HAUSER A. Treatment of hirudin overdosage in a patient with chronic renal failure, (letter) Thromb Haemostas 81:323-324,1999
13. BUCHA E, MARKWARDT F, NOWAK G. Hirudin in hemodialysis. Thromb Res 60:445-455, 1990
14. RIESS FC, PöTZSCH B, JäGER K, BLEESE N, SCHäFER W, MüLLERBERGHAUS G. Elimination von rekombinantem hirudin aus der blutzirkulation mittels hämofiltration. Hämostaseologie 17:200204, 1997
15. NOWAK G, BUCHA E, BRAUNS I, CZERWINSKI R. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). Wien Klin Wochenschr 109:354-358, 1997
16. PöTZSCH B, HUND S, MADLENER K, UNKRIG C, MüLLER-BERGHAUS G. Monitoring of recombinant hirudin. Assessment of a plasmabased ecarin clotting time assay. Thromb Res 86:373-378, 1997 .
17. LAU AH, KRONFOL NO. Determinants of drug removal by continuous hemofiltration. Int J Artif Organs 17:373-378, 1994
18. LAU AH, KRONFOL NO, BARAKAT M. Effect of blood and ultrafiltrate flow rates on drug sieving during continuous hemofiltration. Trans Am Soc Artif Intern Organs 32:297-299, 1987
19. KRONFOL NO, LAU AH, COLON-RIVERA J, LIBERTIN CL. Effect of CAVH membranes types on drug-sieving coefficients and clearances. Trans Am Soc Artif Intern Organs 32:85-87, 1986
20. PHILLIPS GJ, DAVIES JG, OLLIFF CJ, KINGSWOOD C, STREET M. Use of in vitro models of haemofiltration and haemodiafiltration to estimate dosage regimens for critically ill patients prescribed cefpirome. y Clin Pliarm Ther 23:353-359, 1998
21. LAU AH, KRONFOL NO. Effect of continuous hemofiltration on phenytoin elimination. Ther Drug Monit 16:53-57, 1994